Related Experiment Video
Updated: Feb 12, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Detection of EGFR Gene Mutation by Mutation-oriented LAMP Method
Naoyuki Matsumoto1, Akira Kumasaka2, Tomohiro Ando2
1Department of Pathology, Tsurumi University School of Dental Medicine, Yokohama, Japan matsumoto-n@tsurumi-u.ac.jp.
Background/Aim:
Epidermal growth factor receptor (EGFR) is a target of molecular therapeutics for non-small cell lung cancer. EGFR gene mutations at codons 746-753 promote constitutive EGFR activation and result in worst prognosis. However, these mutations augment the therapeutic effect of EGFR-tyrosine kinase inhibitor. Therefore, the detection of EGFR gene mutations is important for determining treatment planning. The aim of the study was to establish a method to detect EGFR gene mutations at codons 746-753.
Materials And Methods:
EGFR gene mutation at codons 746-753 in six cancer cell lines were investigated. A loop-mediated isothermal amplification (LAMP)-based procedure was developed, that employed peptide nucleic acid to suppress amplification of the wild-type allele.
Results:
This mutation-oriented LAMP can amplify the DNA fragment of the EGFR gene with codons 746-753 mutations within 30 min. Moreover, boiled cells can work as template resources.
Conclusion:
Mutation oriented-LAMP assay for EGFR gene mutation is sensitive on extracted DNA. This procedure would be capable of detecting EGFR gene mutation in sputum, pleural effusion, broncho-alveolar lavage fluid or trans-bronchial lung biopsy by chair side.
Insights
A new loop-mediated isothermal amplification (LAMP) method rapidly detects epidermal growth factor receptor (EGFR) gene mutations at codons 746-753. This advancement aids in personalized treatment planning for non-small cell lung cancer patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Epidermal growth factor receptor (EGFR) is a key therapeutic target in non-small cell lung cancer (NSCLC).
- Specific EGFR gene mutations (codons 746-753) are linked to poor prognosis but enhance tyrosine kinase inhibitor efficacy.
- Accurate detection of these mutations is crucial for guiding NSCLC treatment strategies.
Purpose of the Study:
- To develop a rapid and sensitive method for detecting EGFR gene mutations at codons 746-753.
- To establish a mutation-oriented assay for improved NSCLC treatment planning.
Main Methods:
- A loop-mediated isothermal amplification (LAMP) based procedure was developed.
- Peptide nucleic acid was utilized to specifically suppress wild-type allele amplification.
- Six cancer cell lines were analyzed for EGFR gene mutations at codons 746-753.
Main Results:
- The mutation-oriented LAMP assay successfully amplified the target EGFR gene fragment with mutations within 30 minutes.
- Boiled cells could be used directly as template DNA, simplifying sample preparation.
- The assay demonstrated sensitivity when used with extracted DNA.
Conclusions:
- The developed mutation-oriented LAMP assay provides a rapid and sensitive method for detecting specific EGFR gene mutations.
- This technique has the potential for chairside detection of EGFR mutations in various clinical samples like sputum and biopsies.
- This assay can significantly aid in personalized treatment decisions for NSCLC patients.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutation, Gene Flow, and Genetic Drift
Viral Mutations
Point and Frameshift Mutations
Mutations in Microorganisms

